2.060USD+0.51%Mkt Cap: 14.72M USDP/E: —Last update: 2026-06-01
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products includ…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap14.72M USD
Enterprise Value18.68M USD
Revenue (TTM)6.59M USD
Gross Profit10.85K USD
Net Income (TTM)-7.96M USD
Revenue/Share2.076 USD
Last Price2.060 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees35
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.60
PEG—
EV/EBITDA-2.43
EV/Revenue2.83
P/S2.15
P/B2.35
EPS (TTM)-8.29
EPS (Forward)-0.55
52W Range
0.250021% of range8.746
52W High8.746 USD
52W Low0.2500 USD
Profitability
Gross Margin20.00%
Oper. Margin49.45%
EBITDA Margin-116.75%
Profit Margin-14677.14%
ROE-287.90%
ROA-32.46%
Growth
Revenue Growth129080.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.39M USD
CapEx (TTM)—
FCF Margin-173.28%
FCF Yield-77.62%
Net Debt5.35M USD
Net Debt/EBITDA-0.69
Balance Sheet
Debt/Equity2.46
Current Ratio0.09
Quick Ratio0.07
Book Value/Sh0.8430 USD
Cash/Share0.1820 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateApr 11, 2025
Analyst Consensus
Rating—
Target (Mean)5.000 USD
Target Range5.000 USD – 5.000 USD
# Analysts1
Ownership
Shares Out.7.16M
Float6.15M
Insiders9.88%
Institutions11.50%
Short Interest
Short Ratio0.2d
Short % Float62.49%
Short % Out.57.09%
Shares Short3.84M
Short (prev mo.)130.62K
Technical
SMA 500.6966 (+195.7%)
SMA 2002.081 (-1.0%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)25.59M
Avg Vol (10d)72.34M
Technical Indicators
RSI (14)62.9
MACD0.5112
MACD Signal0.3941
MACD Hist.+0.1171
BB Upper3.154 USD
BB Middle1.205 USD
BB Lower-0.7438 USD
BB Width323.45%
ATR (14)0.4725 USD
Vol Ratio (20d)0.06x